Maybe you aren't just tired. It could be heart failure. Here are they key symptoms of ATTR-CM to pay attention to.

The buildup of amyloid protein primarily affects the heart, kidneys, lungs, skin, tongue, nerves, and intestines. It may also occur in association with multiple myeloma (Smith, 2003). Secondary ...

In its first full quarter, Attruby made more headway than analysts anticipated in its competition with Pfizer’s market-leading drug.

BridgeBio's new heart drug — a rival to Pfizer's blockbuster Vyndaqel — smashed sales expectations in its first full quarter ...

“Transthyretin amyloidosis with cardiomyopathy (ATTR-CM ... Sheikh, MD, attending physician in the Advanced Heart Failure Program at MedStar Heart & Vascular Institute at Georgetown University ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to acoramidis (Beyonttra) for adult ...

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis ...

ATTR is characterised by the formation of amyloid fibril deposits in tissues and organs – in the heart in the case of patients with cardiomyopathy. NI006 is an antibody that binds to the ...

When left untreated, patients with hereditary ATTR amyloidosis develop polyneuropathy, which can result in a loss of sensation in the lower limbs and hands, problems affecting the heart ...

UK MHRA grants marketing authorization to Bayer’s acoramidis to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy: United Kingdom Monday, April ...

A person whose kidneys have been destroyed by amyloidosis may receive a kidney transplant. Someone with heart problems may receive a heart transplant, although it is rare. However, transplanted ...